Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/11/2010 | CA2761489A1 High penetration prodrug compositions of peptides and peptide-related compounds |
11/11/2010 | CA2761310A1 Antibodies and methods of use thereof |
11/11/2010 | CA2760977A1 Peptide ligands of somatostatin receptors |
11/11/2010 | CA2760957A1 Novel compositions for treating pseudomonas infection |
11/11/2010 | CA2760787A1 Combined measles-malaria vaccine |
11/11/2010 | CA2760674A1 Fgf21 mutants and uses thereof |
11/11/2010 | CA2760196A1 Fgf21 mutants and uses thereof |
11/11/2010 | CA2760159A1 Methods of treating bacterial infections using oritavancin |
11/11/2010 | CA2759848A1 Anti-il-17f antibodies and methods of use thereof |
11/11/2010 | CA2757874A1 Short-chain peptides as parathyroid hormone (pth) receptor agonist |
11/10/2010 | EP2248901A1 Streptogramines and method for preparing same by mutasynthesis |
11/10/2010 | EP2248900A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
11/10/2010 | EP2248899A1 NOGO receptor binding protein |
11/10/2010 | EP2248895A2 Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent |
11/10/2010 | EP2248892A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function |
11/10/2010 | EP2248832A1 A g-csf conjugate modified by water-soluble polymer |
11/10/2010 | EP2248830A1 Use of antagonist anti-CD40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
11/10/2010 | EP2248828A1 Method for treating inflammation |
11/10/2010 | EP2248822A2 Meningococcus adhesins |
11/10/2010 | EP2248535A1 Multicomponent meningococcal vaccine |
11/10/2010 | EP2248532A1 Protein kinase modulation by hops and acacia products cross-reference to related applications |
11/10/2010 | EP2248531A1 Antidiabetic oral insulin-biguanide combination |
11/10/2010 | EP2248530A1 Novel compositions for treating pseudomonas infection |
11/10/2010 | EP2248529A1 Modulation of NKG2D |
11/10/2010 | EP2248528A1 Use of compositions comprising Dkk2 and fragments thereof for the stimulation or enhancement of bone formation |
11/10/2010 | EP2248527A2 Compositions and methods for the control, prevention, and treatment of obesity and eating disorders |
11/10/2010 | EP2248518A1 Formulation for stabilizing proteins, which is free of mammalian excipients |
11/10/2010 | EP2247745A1 Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
11/10/2010 | EP2247744A1 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
11/10/2010 | EP2247730A1 Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction |
11/10/2010 | EP2247719A1 Siva 2 stabilization |
11/10/2010 | EP2247614A1 Methods and compositions using klotho-fgf fusion polypeptides |
11/10/2010 | EP2247613A1 Cosmetic and dermatological formulations of mntf peptides |
11/10/2010 | EP2247612A1 Siva 3, its preparation and use |
11/10/2010 | EP2247608A2 Biological materials and uses thereof |
11/10/2010 | EP2247605A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
11/10/2010 | EP2247311A1 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
11/10/2010 | EP2247309A2 Tapasin augmentation for enhanced immune response |
11/10/2010 | EP2247303A1 Haemostasis- modulating compositions and uses therefor |
11/10/2010 | EP2247302A1 An engineered cxcl12 alpha locked dimer polypeptide |
11/10/2010 | EP2247300A2 Mntf peptide compositions and methods of use |
11/10/2010 | EP2247299A1 Molecular targets for treatment of inflammation |
11/10/2010 | EP2247298A2 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
11/10/2010 | EP2247297A2 Therapeutic treatment for lung conditions |
11/10/2010 | EP2247295A1 Composition for improving liver metabolism and diagnostic method |
11/10/2010 | EP2247282A1 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
11/10/2010 | EP2247258A1 Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein |
11/10/2010 | EP1996217B1 Novel antibiotic compositions |
11/10/2010 | EP1981908B1 Novel fsh glycosylation variant d3n |
11/10/2010 | EP1616183B1 Methods of detecting neurological disorders |
11/10/2010 | EP1556081B1 Recombinant intracellular pathogen immunogenic compositions and methods for use |
11/10/2010 | EP1531836B1 Polypeptide cleavage process |
11/10/2010 | EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof |
11/10/2010 | EP1411951B2 Enteral compositions for the prevention and/or treatment of sepsis |
11/10/2010 | EP1381627B1 Polypeptides derived from amyloid precursor peptide (app) and their uses |
11/10/2010 | EP1265915B1 Novel compounds |
11/10/2010 | EP1073679B1 Peptide fragments of murine epidermal growth factor as laminin receptor targets |
11/10/2010 | EP1030867B1 Mammalian milk growth factor |
11/10/2010 | EP1015477B1 32 Human secreted proteins |
11/10/2010 | EP0958362B1 Isolation and use of motoneuronotrophic factors |
11/10/2010 | CN1950104B Medicament for the treatment of fungal infections, particularly aspergillosis |
11/10/2010 | CN1929856B An agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor |
11/10/2010 | CN1927387B Application of interleukins-15 in preparation of medicine for tumor immunization therapy and immunotherapy drug |
11/10/2010 | CN1809587B Materials and methods relating to g-protein coupled receptor oligomers |
11/10/2010 | CN1798840B Nogo受体结合蛋白 Nogo receptor-binding protein |
11/10/2010 | CN1784248B Needleless syringe having medical agent accommodated therein |
11/10/2010 | CN1775946B Enhanced virus-mediated DNA transfer |
11/10/2010 | CN1561208B Methods to mobilize progenitor/stem cells |
11/10/2010 | CN101883785A New non-selective somatostatin analogues |
11/10/2010 | CN101883609A Rapid acting injectable insulin compositions |
11/10/2010 | CN101883579A Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders |
11/10/2010 | CN101883578A Use of VEGFR-2 inhibitors for treating metastatic cancer |
11/10/2010 | CN101883577A Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent |
11/10/2010 | CN101883576A A micro-rna family that modulates fibrosis and uses thereof |
11/10/2010 | CN101883574A Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
11/10/2010 | CN101883570A Novel synthesis of beta-nucleosides |
11/10/2010 | CN101880701A New method for preparing aprotinin derivatives by using methanol yeast |
11/10/2010 | CN101880670A 植物血红蛋白 Plants hemoglobin |
11/10/2010 | CN101880656A Agkistrodon halys venom thrombin and preparation method and application thereof |
11/10/2010 | CN101880327A Scorpion arialgesic anti-tumoral peptide fusion and acquisition method thereof |
11/10/2010 | CN101880326A Interferon-beta composite |
11/10/2010 | CN101880319A Antalgic active peptide GRR and preparation and application thereof |
11/10/2010 | CN101880315A Branch oligopeptide with analgesic activity, preparation method and application thereof |
11/10/2010 | CN101879315A Polymalic acid prodrug derivant and applications thereof |
11/10/2010 | CN101879310A Application of human urinary kallidinogenase in preparing medicine for treating diabetic nephropathy |
11/10/2010 | CN101879309A Application of human urinary kallidinogenase in preparing medicine for treating diabetic foot ulcers |
11/10/2010 | CN101879308A Application of human urinary kallidinogenase in preparing medicine for treating acute renal failureacute renal failure |
11/10/2010 | CN101879307A Preparation for repairing active cells |
11/10/2010 | CN101879306A Application of quasi adiponectin polypeptide segments used in drug for curing hypoxic-ischemic encephalopathy (HIE) |
11/10/2010 | CN101879305A Application of serum thymic factors to preparation of anti-tumor medicine and protection medicine of tumor physical and chemical treatment medicine |
11/10/2010 | CN101879304A Functions of placenta polypeptide injection in treating bone injury and healing wound surfaces |
11/10/2010 | CN101878849A Polypeptide powder of crocodile and preparation method and application thereof |
11/10/2010 | CN101337071B Composition for preparing anti-cataract products |
11/10/2010 | CN101314026B Serositis in duckling vaccine oral liquid synergistic agent for poultry biology and preparation method thereof |
11/10/2010 | CN101259265B Deep-sea fish collagen oral liquid |
11/10/2010 | CN101173270B Method for improving secernment efficiency of recombined protein |
11/10/2010 | CN101134773B Method for extracting corn free radical scavenger |
11/10/2010 | CN101134100B Use of steroid hormone synthesized acute regulation protein in the preparation of medicament for preventing and controlling fatty liver |
11/10/2010 | CN101116670B Application of compound capable of providing active methyl or of taking part in the diversion of methyl in the preparation of medicine for treating virosis |
11/10/2010 | CN101104856B Series of non-viral vectors and pharmaceutical composition containing the same |